Showing results (1-10 of 1,590) with videos related to
Sort By:
Pageof 159
Archives of Osteoporosis|December 12, 2022
Two-country comparison of the prescription of bone protection medication before and early after hip fractureNicole K Halim, Roger G Harris, Ian D Cameron, et al.Archives of Osteoporosis|June 27, 2022
Prevalence and patterns of anti-osteoporotic drug use based on 2019 real-world nationwide data in GreeceMaria P Yavropoulou, Polyzois Makras, Kostas Athanasakis, et al.Archives of Osteoporosis|June 28, 2022
Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working GroupP Chotiyarnwong, E V McCloskey, N C Harvey, et al.Archives of Osteoporosis|May 6, 2022
An 11-year longitudinal analysis of refracture rates and public hospital service utilisation in Australia's most populous stateJennifer Williamson, Zoe Michaleff, Francisco Schneuer, et al.Archives of Osteoporosis|March 20, 2020
Oolong tea drinking boosts calcaneus bone mineral density in postmenopausal women: a population-based study in southern ChinaPengfei Duan, Jiahong Zhang, Jialian Chen, et al.Archives of Osteoporosis|March 30, 2020
Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosusEe-Ling Lai, Wen-Nan Huang, Hsin-Hua Chen, et al.Archives of Osteoporosis|March 1, 2020
Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective studyAndrew M McDonald, Eddy S Yang, Kenneth G Saag, et al.Archives of Osteoporosis|October 3, 2020
Respiratory impairment impacts QOL in osteogenesis imperfecta independent of skeletal abnormalitiesElizabeth A Yonko, Jillian S Emanuel, Erin M Carter, et al.Archives of Osteoporosis|October 3, 2020
Effect of increased serum 25(OH)D and calcium on structure and function of post-menopausal women: a pilot studyH J Hillstrom, R Soeters, M Miranda, et al.Archives of Osteoporosis|January 4, 2020
No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysisLaurence Ferrieres, Yannick Degboe, Michel Laroche, et al.Pageof 159